FDA Inspection 1272560 — Holy Name Hospital IRB

Holy Name Hospital IRB — FEI 1000080708

The FDA completed an inspection of Holy Name Hospital IRB on May 28, 2025 in Teaneck, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 28, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Teaneck, NJ (United States)

Additional Details

IRB